Life Style Modification for Breast Canccer Survivors Using Mobile App-based Human Coaching Program

August 16, 2022 updated by: So-Youn Jung, National Cancer Center, Korea

A Prospective Study on the Effect of Quality of Life and Life Style Modification for Breast Cancer Survivors Using Mobile App-based Human Coaching Program

This study is aimed to investigate whether mobile app-based human coaching program for 6 months is effective for reducing BMI in breast cancer survivors with overweight and obesity.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

130

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
    • Gyeonggi-do
      • Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769
        • National Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

breast cancer survivors with 25 and more than 25 of BMI

Description

Inclusion Criteria:

  1. breast cancer survivors who have completed acute treatment of breast cancer
  2. Age: 18 ~ 70 year old
  3. stage: I, II, III
  4. BMI≥25.0 Kg/m2
  5. breast cancer survovrs who can use mobile application program
  6. breast cancer survovrs who agree with this study's consent

Exclusion Criteria:

  1. Stage IV, carcinoma in situ
  2. breast cancer survivors who don't use smartphone
  3. breast cancer survivors with previous other malignant disease
  4. breast cancer survivors with multiple malignancies
  5. breast cancer survivors with uncontrolled chronic comorbid disease
  6. breast cancer survovrs who disagree with this study's consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Breast cancer survivors with over-weight or obesity
Breast cancer survivors with 25 and more than 25 of BMI will be supported with 6 months life style modification program using mobile application including human coach for reducing BMI.
Other: mobile application program with human coach
6-months mobile application program with human coach for life-style modifiation including diet and exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
reduction of body mass index (BMI)
Time Frame: Baseline and 6 month
whether the 6-month mobile program can be effective for reducing BMI
Baseline and 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Cancer Center, Korea

Investigators

  • Principal Investigator: So-Youn Jung, MD PhD, Center for Breast Cancer, National Cancer Center, Korea

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 14, 2019

Primary Completion (ACTUAL)

December 31, 2021

Study Completion (ACTUAL)

June 30, 2022

Study Registration Dates

First Submitted

August 16, 2022

First Submitted That Met QC Criteria

August 16, 2022

First Posted (ACTUAL)

August 18, 2022

Study Record Updates

Last Update Posted (ACTUAL)

August 18, 2022

Last Update Submitted That Met QC Criteria

August 16, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NCC 2019-0098

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe